» Articles » PMID: 35198075

Exosome-mediated Delivery of RBP-J Decoy Oligodeoxynucleotides Ameliorates Hepatic Fibrosis in Mice

Overview
Journal Theranostics
Date 2022 Feb 24
PMID 35198075
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages play multi-dimensional roles in hepatic fibrosis. Studies have implicated Notch signaling mediated by the transcription factor RBP-J in macrophage activation and plasticity. Additionally, we have previously shown that myeloid-specific disruption of RBP-J can ameliorate hepatic fibrosis in mice. Accordingly, we next asked whether blocking Notch signaling in macrophages could serve as a therapeutic strategy to treat hepatic fibrosis. In this study, we used a combination of transcription factor decoy oligodeoxynucleotides (ODNs) and exosomes to test this possibility. Hairpin-type decoy oligodeoxynucleotides (ODNs) were designed for the transcription factor RBP-J. The effects of RBP-J decoy ODNs on Notch signaling were evaluated by western blot, quantitative RT-PCR, luciferase reporter assays, and electrophoretic mobility shift assays. ODNs were loaded into HEK293T-derived exosomes by electroporation. A hepatic fibrosis mouse model was established by the intraperitoneal injection of carbon tetrachloride or bile duct ligation. Mice with hepatic fibrosis were administered exosomes loaded with RBP-J decoy ODNs tail vein injection. The distribution of exosomes was analyzed by fluorescence labeling and imaging. Liver histology was examined using hematoxylin and eosin, Sirius red, and Masson staining, as well as immunohistochemical staining for Col1α1 and αSMA. We found that RBP-J decoy ODNs could be efficiently loaded into exosomes and inhibit the activation of Notch signaling. Furthermore, exosomes administered the tail vein were found to be primarily taken up by hepatic macrophages in mice with liver fibrosis. Importantly, RBP-J decoy ODNs delivered by exosomes could efficiently inhibit Notch signaling in macrophages and ameliorate hepatic fibrosis in mice. Combined, our data showed that the infusion of exosomes loaded with RBP-J decoy ODNs represents a promising therapeutic strategy for the treatment of hepatic fibrosis.

Citing Articles

Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis.

Liu Y, Wang L eGastroenterology. 2025; 2(1):e100040.

PMID: 39944750 PMC: 11770438. DOI: 10.1136/egastro-2023-100040.


Exosome-equipped TNF antisense oligodeoxynucleotide or 2-deoxy-D-glucose ameliorated nonalcoholic steatohepatitis by modulating superoxide dismutase 1 in mice.

He F, Du W, Liu Y, Ling Y, Xu M, Liu J Redox Biol. 2025; 80:103488.

PMID: 39778469 PMC: 11763583. DOI: 10.1016/j.redox.2025.103488.


Effects of exosomes from human dental pulp stem cells on the biological behavior of human fibroblasts.

Chen G, Fu L, Ye H, Cheng P, Feng H, Yan M Sci Rep. 2025; 15(1):1134.

PMID: 39774130 PMC: 11707004. DOI: 10.1038/s41598-024-78388-1.


The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?.

Tao X, Chen C, Liu M Biomedicines. 2025; 12(12.

PMID: 39767572 PMC: 11726879. DOI: 10.3390/biomedicines12122665.


Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis.

Li J, Yuan Y, Fu Q, Chen M, Liang H, Chen X Biomark Res. 2024; 12(1):119.

PMID: 39396032 PMC: 11470730. DOI: 10.1186/s40364-024-00669-8.


References
1.
Imai T, Takahashi Y, Nishikawa M, Kato K, Morishita M, Yamashita T . Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 2015; 4:26238. PMC: 4323410. DOI: 10.3402/jev.v4.26238. View

2.
van der Heide D, Weiskirchen R, Bansal R . Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases. Front Immunol. 2019; 10:2852. PMC: 6901832. DOI: 10.3389/fimmu.2019.02852. View

3.
Mehta M, Paudel K, Shukla S, Rama Raju Allam V, Kannaujiya V, Panth N . Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. J Control Release. 2021; 337:629-644. DOI: 10.1016/j.jconrel.2021.08.010. View

4.
Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L . Reassessment of Exosome Composition. Cell. 2019; 177(2):428-445.e18. PMC: 6664447. DOI: 10.1016/j.cell.2019.02.029. View

5.
Zhang W, Xu W, Xiong S . Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol. 2010; 184(11):6465-78. DOI: 10.4049/jimmunol.0904016. View